Yasser El-Sayed, Professor
Randomized, double blind trial of magnesium sulfate tocolysis versus intravenous saline for suspected placental abruption
Contact Information
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Brief
To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.
Recruiting Status:
RecruitingStanford Recruiting Status:
RecruitingCondition(s):
Intervention(s):
- Drug: magnesium sulfate
Phase:
N/AEligibility
Ages Eligible for Study:
18 years to Any AgeGenders Eligible for Study:
FemaleHealth of Volunteers:
People with the conditions listed in this trial can participate as controls.Key Inclusion Criteria:
:
- vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation.
Key Exclusion Criteria:
- preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress
Additional Study Details
Official Title:
Randomized, double blind trial of magnesium sulfate tocolysis versus intravenous saline for suspected placental abruptionAnticipated start date:
3/31/2004Lead Sponsor:
Stanford UniversityCollaborator(s):
Investigator(s):
Study Type:
InterventionalPurpose:
TreatmentAllocation:
RandomizedMasking:
Double BlindControl:
noneAssignment:
Single GroupEndpoints:
UnspecifiedPrimary Outcomes:
- resolution of vaginal bleeding and contractions
Secondary Outcomes:
- preterm delivery
- neonatal outcomes
Total Number to be Enrolled:
48Total Number to be Enrolled at Stanford:
24More Information
Secondary ID(s):
- NONE
Locations & Contacts
Stanford Locations & Contacts:
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Non-Stanford Locations:
This study is being conducted at multiple locations, including non-Stanford locations.
This listing was last updated:
5/18/2009PLEASE NOTE:
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.
Help